BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28882567)

  • 21. Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA.
    Alméciga-Diaz CJ; Hidalgo OA; Olarte-Avellaneda S; Rodríguez-López A; Guzman E; Garzón R; Pimentel-Vera LN; Puentes-Tellez MA; Rojas-Rodriguez AF; Gorshkov K; Li R; Zheng W
    J Med Chem; 2019 Jul; 62(13):6175-6189. PubMed ID: 31188588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes.
    Sukegawa K; Nakamura H; Kato Z; Tomatsu S; Montaño AM; Fukao T; Toietta G; Tortora P; Orii T; Kondo N
    Hum Mol Genet; 2000 May; 9(9):1283-90. PubMed ID: 10814710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A general binding mechanism for all human sulfatases by the formylglycine-generating enzyme.
    Roeser D; Preusser-Kunze A; Schmidt B; Gasow K; Wittmann JG; Dierks T; von Figura K; Rudolph MG
    Proc Natl Acad Sci U S A; 2006 Jan; 103(1):81-6. PubMed ID: 16368756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.
    Rodríguez-López A; Pimentel-Vera LN; Espejo-Mojica AJ; Van Hecke A; Tiels P; Tomatsu S; Callewaert N; Alméciga-Díaz CJ
    J Pharm Sci; 2019 Aug; 108(8):2534-2541. PubMed ID: 30959056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The iron sulfur protein AtsB is required for posttranslational formation of formylglycine in the Klebsiella sulfatase.
    Szameit C; Miech C; Balleininger M; Schmidt B; von Figura K; Dierks T
    J Biol Chem; 1999 May; 274(22):15375-81. PubMed ID: 10336424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The heparin/heparan sulfate 2-O-sulfatase from Flavobacterium heparinum. Molecular cloning, recombinant expression, and biochemical characterization.
    Myette JR; Shriver Z; Claycamp C; McLean MW; Venkataraman G; Sasisekharan R
    J Biol Chem; 2003 Apr; 278(14):12157-66. PubMed ID: 12519775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaerobic sulfatase-maturating enzyme--a mechanistic link with glycyl radical-activating enzymes?
    Benjdia A; Subramanian S; Leprince J; Vaudry H; Johnson MK; Berteau O
    FEBS J; 2010 Apr; 277(8):1906-20. PubMed ID: 20218986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Function and structure of a prokaryotic formylglycine-generating enzyme.
    Carlson BL; Ballister ER; Skordalakes E; King DS; Breidenbach MA; Gilmore SA; Berger JM; Bertozzi CR
    J Biol Chem; 2008 Jul; 283(29):20117-25. PubMed ID: 18390551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The non-catalytic N-terminal extension of formylglycine-generating enzyme is required for its biological activity and retention in the endoplasmic reticulum.
    Mariappan M; Gande SL; Radhakrishnan K; Schmidt B; Dierks T; von Figura K
    J Biol Chem; 2008 Apr; 283(17):11556-64. PubMed ID: 18305113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-dimensional structures of sulfatases.
    Ghosh D
    Methods Enzymol; 2005; 400():273-93. PubMed ID: 16399355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase.
    Tomatsu S; Montaño AM; Gutierrez M; Grubb JH; Oikawa H; Dung VC; Ohashi A; Nishioka T; Yamada M; Yamada M; Tosaka Y; Trandafirescu GG; Orii T
    Mol Genet Metab; 2007 May; 91(1):69-78. PubMed ID: 17336563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activities of sulfatases for the degradation of acidic glycosaminoglycans in cultured skin fibroblasts from two siblings with multiple sulfatase deficiency.
    Minami R; Fujibayashi S; Tachi N; Wagatsuma K; Nakao T; Ikeno T; Tsugawa S; Sukegawa K; Orii T
    Clin Chim Acta; 1983 Apr; 129(2):175-80. PubMed ID: 6851160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression, activity and localization of lysosomal sulfatases in Chronic Obstructive Pulmonary Disease.
    Weidner J; Jogdand P; Jarenbäck L; Åberg I; Helihel D; Ankerst J; Westergren-Thorsson G; Bjermer L; Erjefält JS; Tufvesson E
    Sci Rep; 2019 Feb; 9(1):1991. PubMed ID: 30760748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttranslational formation of formylglycine in prokaryotic sulfatases by modification of either cysteine or serine.
    Dierks T; Miech C; Hummerjohann J; Schmidt B; Kertesz MA; von Figura K
    J Biol Chem; 1998 Oct; 273(40):25560-4. PubMed ID: 9748219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-translational formylglycine modification of bacterial sulfatases by the radical S-adenosylmethionine protein AtsB.
    Fang Q; Peng J; Dierks T
    J Biol Chem; 2004 Apr; 279(15):14570-8. PubMed ID: 14749327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaerobic sulfatase-maturating enzymes, first dual substrate radical S-adenosylmethionine enzymes.
    Benjdia A; Subramanian S; Leprince J; Vaudry H; Johnson MK; Berteau O
    J Biol Chem; 2008 Jun; 283(26):17815-26. PubMed ID: 18408004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin/heparan sulfate 6-O-sulfatase from Flavobacterium heparinum: integrated structural and biochemical investigation of enzyme active site and substrate specificity.
    Myette JR; Soundararajan V; Shriver Z; Raman R; Sasisekharan R
    J Biol Chem; 2009 Dec; 284(50):35177-88. PubMed ID: 19726671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterologous expression in Pichia pastoris and biochemical characterization of the unmodified sulfatase from Fusarium proliferatum LE1.
    Korban SA; Bobrov KS; Maynskova MA; Naryzhny SN; Vlasova OL; Eneyskaya EV; Kulminskaya AA
    Protein Eng Des Sel; 2017 Jul; 30(7):477-488. PubMed ID: 28651356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a sandwich enzyme linked immunosorbent assay (ELISA) for the quantification of iduronate-2-sulfate sulfatase.
    Sosa AC; Espejo AJ; Rodriguez EA; Lizaraso LM; Rojas A; Guevara J; Echeverri OY; Barrera LA
    J Immunol Methods; 2011 May; 368(1-2):64-70. PubMed ID: 21447345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfotransferases, sulfatases and formylglycine-generating enzymes: a sulfation fascination.
    Bojarová P; Williams SJ
    Curr Opin Chem Biol; 2008 Oct; 12(5):573-81. PubMed ID: 18625336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.